P/E ratio for ANI Pharmaceuticals (ANIP)

P/E ratio history for ANI Pharmaceuticals from 2001 to 2023

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Jazz Pharmaceuticals JAZZ	-89.8	-25.81%	🇮🇪 Ireland
Evoke Pharma EVOK	-1.83	-98.48%	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	-8.56	-92.93%	🇮🇱 Israel
Pfizer PFE	13.8	-111.39%	🇺🇸 USA
Lannett Company LCI	-0.0271	-99.98%	🇺🇸 USA
Celldex Therapeutics CLDX	-11.3	-90.70%	🇺🇸 USA
Cardinal Health CAH	121	-199.63%	🇺🇸 USA
Novartis NVS	27.9	-123.03%	🇨🇭 Switzerland
Royalty Pharma RPRX	48.1	-139.69%	🇬🇧 UK

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.